<i>In vitro</i> and <i>in vivo</i> oxidative metabolism and glucuronidation of anastrozole
Landry K. Kamdem(Harding University Main Campus), Zeruesenay Desta(Indiana University School of Medicine), Susan Kadlubar(University of Arkansas for Medical Sciences), Vered Stearns(Johns Hopkins University), Mark J. Ratain(University of Chicago), Jacqueline Ramı́rez(University of Chicago), David A. Flockhart(Indiana University – Purdue University Indianapolis), Yong Liu(Tango Therapeutics (United States)), Stacie C. Jeter(Johns Hopkins University), Karineh Shahverdi(Johns Hopkins University), Evan T. Ogburn(Indiana University School of Medicine), Bryan A. Ward(Indiana University School of Medicine)
Cited by 79
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947
Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
|JNCI Journal of the National Cancer Institute|2003|850